- Original article
- Open access
- Published:
Study of upper airway inflammation in patients with obstructive sleep apnea–hypopnea syndrome
Egyptian Journal of Bronchology volume 13, pages 754–759 (2019)
Abstract
Background
Pharyngeal lavage was reported as a novel technique for noninvasive assessment of inflammation of the pharynx.
Aim
To study upper airway inflammation in patients with obstructive sleep apnea–hypopnea syndrome (OSAHS) and its correlation with systemic inflammation.
Patients and methods
A total of 36 patients with known OSAHS, admitted to the Chest Department, Alexandria Main University Hospital (group I), and 15 healthy volunteers (group II) were enrolled into the study. Informed consent was taken from all participants. The two groups underwent complete history taking, assessment of BMI, measurement of serum C-reactive protein (CRP), overnight polysomnography, and oropharyngeal lavage (OPL) analysis.
Results
In group I, the most prevalent cell type of OPL was lymphocytes followed by neutrophils. Compared with control group (group II), the most prevalent cell type in OPL was macrophages followed by epithelial cells. Regarding the OPL differential cell count which denotes local pharyngeal inflammation, there was a statistically significant difference between both groups (P<0.001). Similarly, CRP, a marker of systemic inflammation, showed a significant statistical difference between both groups (P<0.001). Strikingly, there was no statistically significant correlation between CRP and apnea–hypopnea index (P=0.604). Snoring, apnea–hypopnea index, and other sleep parameters correlated significantly with lymphocytic predominance in OPL (P<0.001), whereas CRP correlates significantly with neutrophils and eosinophil’s in OPL (P<0.001 and P=0.015, respectively).
Conclusion
Our study had provided a novel vision into the pathophysiology of OSAHS in emphasizing the existence of upper airway lymphocytic inflammation. OPL is a simple, applicable, and easy noninvasive procedure for assessment of upper airway inflammation.
References
Entzian P, Linnemann K, Schlaak M, Zabel P. Obstructive sleep apnea and circadian rhythms of hormones and cytokines. Am J Respir Crit Care Med 1996; 153:1080–1086.
Hatipoğlu U, Rubinstein I. Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 2003; 70:665–671.
Sekosan M, Zakkar M, Wenig B, Olopade CO, Rubinstein I. Inflammation in the uvula mucosa of patients with obstructive sleep apnea. Laryngoscope 1996; 106:1018–1020.
Boyd JH, Petrof BJ, Hamid Q, Fraser R, Kimoff RJ. Upper airway muscle inflammation and denervation changes in obstructive sleep apnea. Am J Respir Crit Care Med 2004; 170:541–546.
Rubinstein I. Nasal inflammation in patients with obstructive sleep apnea. Laryngoscope 1995; 105:175–177.
Tauman R, Ivanenko A, O’Brien LM, Gozal D. Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics 2004; 113:564–569.
Larkin EK, Rosen CL, Kirchner HL, Storfer-Isser A, Emancipator JL, Johnson NL, et al. Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation 2005; 111:1978–1984.
Vicente E, Marin JM, Carrizo SJ, Osuna CS, González R, Marin-Oto M, et al. Upper airway and systemic inflammation in obstructive sleep apnea. Eur Respir J 2016; 48:1108–1117.
Reid MB, Lännergren J, Westerblad H. Respiratory and limb muscle weakness induced by tumor necrosis factor-alpha: involvement of muscle myofilaments. Am J Respir Crit Care Med 2002; 166:479–484.
Huxtable AG, Vinit S, Windelborn JA, Crader SM, Guenther CH, Watters JJ, et al. Systemic inflammation impairs respiratory chemoreflexes and plasticity. Respir Physiol Neurobiol 2011; 178:482–489.
Hauber HP, Rüller S, Müller E, Hansen E, Zabel P. Pharyngeal lavage lymphocytosis in patients with obstructive sleep apnea: a preliminary observation. 2011. PLoS One 2011; 6:e16277.
Almendros I, Carreras A, Ramirez J, Montserrat JM, Navajas D, Farré R. Upper airway collapse and reopening induce inflammation in a sleep apnea model. Eur Respir J 2008; 32:399–404.
Li AM, Hung E, Tsang T, Yin J, So HK, Wong E, et al. Induced sputum inflammatory measures correlate with disease severity in children with obstructive sleep apnea. Thorax 2007; 62:75–79.
Devouassoux G, Lévy P, Rossini E, Pin I, Fior-Gozlan M, Henry M, et al. Sleep apnea is associated with bronchial inflammation and continuous positive airway pressure-induced airway hyper responsiveness. J Allergy Clin Immunol 2007; 119:597–603.
Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis 2009; 51:434–451.
Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003; 107:1129–1134.
Taheri S, Austin D, Lin L, Nieto FJ, Young T, Mignot E. Correlates of serum C-reactive protein (CRP): no association with sleep duration or sleep disordered breathing. Sleep 2007; 30:991–996.
Arnardottir ES, Maislin G, Schwab RJ, Staley B, Benediktsdottir B, Olafsson I, et al. The interaction of obstructive sleep apnea and obesity on the inflammatory markers C-reactive protein and interleukin-6: the Icelandic Sleep Apnea Cohort. Sleep 2012; 35:921–932.
Salerno FG, Carpagnano E, Guido P, Bonsignore MR, Roberti A, Aliani M, et al. Airway inflammation in patients affected by obstructive sleep apnea syndrome. Respir Med 2004; 98:25–28.
Guilleminault C, Kirisoglu C, Ohayon MM. C-reactive protein and sleep-disordered breathing. Sleep 2004; 27:1507–1511.
Chirinos JA, Gurubhagavatula I, Teff K, Rader TD, Wadden TA, Townsend R, et al. CPAP, weight loss, or both for obstructive sleep apnea. N Engl J Med 2014; 370:2265–2275.
Youssef HA, Shalaby AO, Shaker OG, Sabry IM, Mahmoud EA. The role of matrix metalloproteinases 2 and 9 in obstructive sleep apnea. Egypt J Bronchol 2014; 8:10–16.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mohamed, E.E., Baess, A.I. & Eldowik, Y.M. Study of upper airway inflammation in patients with obstructive sleep apnea–hypopnea syndrome. Egypt J Bronchol 13, 754–759 (2019). https://doi.org/10.4103/ejb.ejb_27_19
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/ejb.ejb_27_19